scispace - formally typeset
R

Rezvan Najafi

Researcher at Hamedan University of Medical Sciences

Publications -  99
Citations -  1850

Rezvan Najafi is an academic researcher from Hamedan University of Medical Sciences. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 20, co-authored 75 publications receiving 1149 citations. Previous affiliations of Rezvan Najafi include University of Tehran & Tehran University of Medical Sciences.

Papers
More filters
Journal ArticleDOI

PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy.

TL;DR: A brief overview of the molecular and biochemical events that are regulated by the PD‐1 and PD‐L1 interaction in various cancers is highlighted.
Journal ArticleDOI

Hypoxia: A Double-Edged Sword in Cancer Therapy.

TL;DR: A review of the role of hypoxia on chemoresistance and radioresistance in malignant tumors and several approaches targeting tumor Hypoxia-targeted therapy are addressed.
Journal ArticleDOI

Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.

TL;DR: A major role of resveratrol is revealed in apoptosis, invasion, and switching of EMT to MET phenotype through upregulation of miR‐200c in CRC.
Journal ArticleDOI

Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats

TL;DR: Preconditioning of M SCs by DFO prior to transplantation could increase homing of MSCs through affecting some chemokine receptors as well as proteases involved and eventually improving the efficacy of cell therapy.
Journal ArticleDOI

All-trans retinoic acid preconditioning enhances proliferation, angiogenesis and migration of mesenchymal stem cell in vitro and enhances wound repair in vivo.

TL;DR: It seems that chemical and pharmacological preconditioning enhances their therapeutic efficacy in cell therapy, and effects of all‐trans retinoic acid (ATRA) on survival, angiogenesis and migration of mesenchymal stem cells in vitro and in a wound‐healing model.